Pharma Mar SA (PHMMF)
87.58
0.00 (0.00%)
USD |
OTCM |
Aug 21, 16:00
Pharma Mar Debt to Equity Ratio : 0.1828 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.1828 |
| March 31, 2026 | 0.1904 |
| December 31, 2025 | 0.1962 |
| September 30, 2025 | 0.2548 |
| June 30, 2025 | 0.255 |
| March 31, 2025 | 0.263 |
| December 31, 2024 | 0.2441 |
| September 30, 2024 | 0.2935 |
| June 30, 2024 | 0.2171 |
| March 31, 2024 | 0.209 |
| December 31, 2023 | 0.2242 |
| September 30, 2023 | 0.2113 |
| June 30, 2023 | 0.2077 |
| March 31, 2023 | 0.20 |
| December 31, 2022 | 0.19 |
| June 30, 2022 | 0.2156 |
| March 31, 2022 | 0.2364 |
| December 31, 2021 | 0.2771 |
| September 30, 2021 | 0.3806 |
| June 30, 2021 | 0.4244 |
| March 31, 2021 | 0.4265 |
| December 31, 2020 | 0.5514 |
| September 30, 2020 | 0.6141 |
| June 30, 2020 | 0.5849 |
| March 31, 2020 | 0.7827 |
| Date | Value |
|---|---|
| December 31, 2019 | 7.567 |
| September 30, 2019 | -16.87 |
| June 30, 2019 | 722.03 |
| March 31, 2019 | 8.646 |
| December 31, 2018 | 4.367 |
| September 30, 2018 | 3.071 |
| June 30, 2018 | 3.659 |
| March 31, 2018 | 3.968 |
| December 31, 2017 | 3.719 |
| September 30, 2017 | 2.530 |
| June 30, 2017 | 2.204 |
| March 31, 2017 | 1.894 |
| December 31, 2016 | 1.243 |
| September 30, 2016 | 1.670 |
| June 30, 2016 | 1.727 |
| March 31, 2016 | 1.517 |
| December 31, 2015 | 0.8036 |
| September 30, 2015 | 1.359 |
| June 30, 2015 | 1.226 |
| March 31, 2015 | 0.8593 |
| December 31, 2014 | 0.9511 |
| September 30, 2014 | 1.370 |
| June 30, 2014 | 1.418 |
| March 31, 2014 | 1.313 |
| December 31, 2013 | 1.229 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Oryzon Genomics SA | 0.0561 |
| Grifols SA | 1.536 |
| ACADIA Pharmaceuticals, Inc. | 0.0565 |
| Alkermes Plc | 0.8695 |
| Alnylam Pharmaceuticals, Inc. | 2.206 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 450.00M |
| Total Liabilities (Quarterly) | 162.32M |
| Shareholders Equity (Quarterly) | 286.71M |
| Current Ratio | 2.855 |
| Net Debt Paydown Yield | 0.05% |